Tine W. Hansen

ORCID: 0000-0003-2274-0352
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Health and Disease Prevention
  • Diabetes Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Management and Research
  • Chronic Kidney Disease and Diabetes
  • Metabolism, Diabetes, and Cancer
  • Protease and Inhibitor Mechanisms
  • Cardiac Imaging and Diagnostics
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pancreatic function and diabetes
  • Cardiovascular Disease and Adiposity
  • Heart Failure Treatment and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Liver Disease Diagnosis and Treatment
  • Diet and metabolism studies
  • Hemodynamic Monitoring and Therapy
  • Hormonal Regulation and Hypertension
  • Lipoproteins and Cardiovascular Health
  • Sodium Intake and Health
  • Retinal Diseases and Treatments
  • Pain Mechanisms and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Adipokines, Inflammation, and Metabolic Diseases

Steno Diabetes Centers
2016-2025

University of Copenhagen
2009-2025

Capital Region of Denmark
2009-2025

Universidad de la República de Uruguay
2008-2023

Danish Diabetes Association
2022-2023

Ruijin Hospital
2008-2023

KU Leuven
2006-2023

Shanghai Institute of Hypertension
2010-2023

Hospital de Clínicas
2008-2023

Anna Needs Neuroblastoma Answers
2023

Few population studies addressed the prognostic significance of aortic pulse wave velocity (APWV) above and beyond other cardiovascular risk factors.We studied a sex- age-stratified random sample 1678 Danes aged 40 to 70 years. We used Cox regression investigate value APWV, office pressure (PP), 24-hour ambulatory PP while adjusting for mean arterial (MAP) covariates. Over median follow-up 9.4 years, incidence fatal nonfatal end points, mortality, coronary heart disease amounted 154, 62, 101...

10.1161/circulationaha.105.579342 article EN Circulation 2006-02-06

In previous studies, of which several were underpowered, the relation between cardiovascular outcome and blood pressure (BP) variability was inconsistent. We followed health outcomes in 8938 subjects (mean age: 53.0 years; 46.8% women) randomly recruited from 11 populations. At baseline, we assessed BP SD average real 24-hour ambulatory recordings. computed standardized hazard ratios (HRs) while stratifying by cohort adjusting for other risk factors. Over 11.3 years (median), 1242 deaths...

10.1161/hypertensionaha.109.140798 article EN Hypertension 2010-03-09

<h3>Importance</h3> Blood pressure (BP) is a known risk factor for overall mortality and cardiovascular (CV)-specific fatal nonfatal outcomes. It uncertain which BP index most strongly associated with these <h3>Objective</h3> To evaluate the association of indexes death composite CV event. <h3>Design, Setting, Participants</h3> Longitudinal population-based cohort study 11 135 adults from Europe, Asia, South America baseline observations collected May 1988 to 2010 (last follow-ups, August...

10.1001/jama.2019.9811 article EN JAMA 2019-08-06

Background We and other investigators previously reported that isolated nocturnal hypertension on ambulatory measurement (INH) clustered with cardiovascular risk factors was associated intermediate target organ damage. investigated whether INH might also predict hard endpoints. Methods results monitored blood pressure (BP) throughout the day followed health outcomes in 8711 individuals randomly recruited from 10 populations (mean age 54.8 years, 47.0% women). Of these, 577 untreated had...

10.1097/hjh.0b013e32833b49fe article EN Journal of Hypertension 2010-06-02

Low-grade inflammation is thought to contribute the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers may aid in risk prediction enable early intervention prevention disease.The aim this study was investigate whether plasma levels inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) are predictive mortality general population.This an observational prospective cohort study. Cohort participants were included...

10.1111/j.1365-2796.2010.02252.x article EN Journal of Internal Medicine 2010-05-28

It is unclear whether subclinical vascular damage adds significantly to Systemic Coronary Risk Evaluation (SCORE) risk stratification in healthy subjects. In a population-based sample of 1968 subjects without cardiovascular disease or diabetes not receiving any cardiovascular, anti-diabetic, lipid-lowering treatment, aged 41, 51, 61, 71 years, we measured traditional factors, left ventricular (LV) mass index, atherosclerotic plaques the carotid arteries, carotid/femoral pulse wave velocity...

10.1093/eurheartj/ehp546 article EN European Heart Journal 2009-12-23

Current diagnostic thresholds for ambulatory blood pressure (ABP) mainly rely on statistical parameters derived from reference populations. We determined an outcome-driven frame ABP measurement.We performed 24-hour monitoring in 5682 participants (mean age 59.0 years; 43.3% women) enrolled prospective population studies Copenhagen, Denmark; Noorderkempen, Belgium; Ohasama, Japan; and Uppsala, Sweden. In multivariate analyses, we thresholds, which yielded 10-year cardiovascular risks similar...

10.1161/circulationaha.106.662254 article EN Circulation 2007-04-10

Previous studies on the prognostic significance of morning blood pressure surge (MS) produced inconsistent results. Using International Database Ambulatory Blood Pressure in Relation to Cardiovascular Outcome, we analyzed 5645 subjects (mean age: 53.0 years; 54.0% women) randomly recruited 8 countries. The sleep-through and preawakening MS were differences with lowest nighttime pressure, respectively. We computed multivariable-adjusted hazard ratios comparing risk ethnic- sex-specific...

10.1161/hypertensionaha.109.137273 article EN Hypertension 2010-03-09
Nete Tofte Morten Lindhardt Katarina Adamova Stephan J. L. Bakker Joachim Beige and 95 more Joline W. J. Beulens Andreas L. Birkenfeld Gemma Currie Christian Delles Ingo Dimos Lidmila Francová Marie Frimodt‐Møller Peter Girman Rüdiger Göke Tereza Havrdova Hiddo J.L. Heerspink Adriaan Kooy Gozewijn D. Laverman Harald Mischak Gerjan Navis Giel Nijpels Marina Noutsou Alberto Ortíz Aneliya Parvanova Frederik Persson John R. Petrie Piero Ruggenenti Femke Rutters Ivan Rychlík Justyna Siwy Goce Spasovski Marijn M. Speeckaert Matias Trillini Petra Zürbig Heiko von der Leyen Peter Rossing Silke Zimmermann Brit Rädisch Anika Hävemeier Annette Busmann Ulrike Wittkop Barbara Neuhaus Regina Ax-Smolarski Veit Zieglschmid Eva Bollweber Heidrun Wölk Viktor Rotbain Curovic Ninna Hahn Tougaard Mie K. Eickhoff Sascha Pilemann-Lyberg Signe Abitz Winther Signe Rosenlund Tine W. Hansen Bernt Johan von Scholten Christian Stevns Hansen Emilie H. Zobel Jens Christian Laursen Simone Theilade Lone Jelstrup Tina R. Juhl Dorthe Riis Jessie A. Hermann Anne G. Lundgaard Maja L.D. Halkjær Lene Aabo Therese Frost Lerche Maria Lajer Rikke J. Stefansen Maria Campbell Annika Durban Julia Raad Michael J. Prigge Marco Schiemann Robbie Wilson Sharon Kean Elizabeth Douglas Pamela Surtees Christina M. Gant Stanley M.H. Yeung Ilse J. M. Hagedoorn Joanne Flynn Joe Galloway Katriona Brooksbank Carolina Aparicio Ilian Iliev Francesco Nones Francesca Lo Bue Daniela Melacini Daniela Cugini Silvia Prandini V. Lecchi Svitlana Yakymchuk Giulia Gherardi Alessandro Villa Davide Villa Flavio Gaspari Antonio Cannatà Silvia Ferrari Nadia Stucchi Šárka Albrechtová

10.1016/s2213-8587(20)30026-7 article EN The Lancet Diabetes & Endocrinology 2020-03-02

The relationship between ambulatory blood pressure and mortality in a general Western population is unknown. Therefore, we conducted this prospective study of random sample 1700 Danish men women, aged 41 to 72 years, without major cardiovascular diseases. At baseline, pressure, office other risk factors were recorded. After mean period 9.5 174 had died: 63 deaths. In multivariate proportional hazards models, adjusted for significance, the relative (95% confidence interval) associated with 10...

10.1161/01.hyp.0000160402.39597.3b article EN Hypertension 2005-03-08

Background:Information on the relationship between ambulatory blood pressure (BP) and cardiovascular disease in general population is sparse.

10.1016/j.amjhyper.2005.09.018 article EN other-oa American Journal of Hypertension 2006-02-22

Abstract The effect of the insulinotropic incretin hormone, glucagon-like peptide-1 (GLP-1), is preserved in typical middle-aged, obese, insulin-resistant type 2 diabetic patients, whereas a defective amplification so-called late-phase plasma insulin response (20–120 min) to glucose by other glucose-dependent polypeptide (GIP), seen these patients. aim present investigation was evaluate and C-peptide responses GLP-1 GIP five groups patients with etiology phenotype distinct from obese We...

10.1210/jc.2003-030738 article EN The Journal of Clinical Endocrinology & Metabolism 2003-10-01

The ambulatory arterial stiffness index (AASI) can be computed from individual 24-h blood pressure recordings.We investigated the prognostic value of AASI and pulse in a random sample 1829 Danes, aged 40-70 years. We adjusted for sex, age, body mass index, mean pressure, smoking, diabetes, ratio total to high-density lipoprotein cholesterol, history cardiovascular disease with Cox regression.Over median follow-up 9.4 years, incidences fatal nonfatal endpoints were 40 stroke, 150 coronary...

10.1097/01.hjh.0000249703.57478.78 article EN Journal of Hypertension 2006-10-18

Outcome-driven recommendations about time intervals during which ambulatory blood pressure should be measured to diagnose white-coat or masked hypertension are lacking. We cross-classified 8237 untreated participants (mean age, 50.7 years; 48.4% women) enrolled in 12 population studies, using ≥140/≥90, ≥130/≥80, ≥135/≥85, and ≥120/≥70 mm Hg as thresholds for conventional, 24-hour, daytime, nighttime pressure. White-coat was on conventional measurement with normotension, the opposite...

10.1161/hypertensionaha.114.03614 article EN Hypertension 2014-08-19
Coming Soon ...